Di Vito M, Garzoli S, Rosato R, Mariotti M, Gervasoni J, Santucci L, Ovidi E, Cacaci M, Lombarini G, Torelli R, Urbani A, Sanguinetti M, Bugli F
Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy.
Dipartimento di Chimica e Tecnologie del Farmaco, Università di Roma Sapienza, Rome, Italy.
Microbiol Spectr. 2023 Mar 28;11(2):e0438522. doi: 10.1128/spectrum.04385-22.
Candida auris is a multidrug-resistant fungus known to be a global public health problem. The skin-based transmission, together with the marked resistance to drugs, resulted in its rapid spread to all continents. The aim of this study was to identify an essential oil (EO) active in the fight against C. auris. A total of 15 EOs were tested against 10 clinical strains of C. auris. EO (CZ-EO) was the most effective (MIC90 and MFC90 equal to 0.06% vol/vol). Three fractions obtained from CZ-EO, and the cinnamaldehyde (CIN), the major chemical compound, were tested to identify the principal compound effectives against C. auris. All CIN-containing samples showed anti-fungal activity. To study the synergy with fluconazole, CZ-EO, its active fraction (FR2), and CIN were tested in checkerboard tests. Results show that CZ-EO and FR2, but not CIN, synergize with fluconazole. Furthermore, only the copresence of CZ-EO or FR2 synergize with fluconazole at therapeutic concentrations of the drug (0.45 ± 0.32 μg/mL and 0.64 ± 0.67 μg/mL, respectively), while CIN only shows additive activity. studies conducted on Galleria mellonella larvae show the absence of toxicity of CZ-EO up to concentrations of 16% vol/vol, and the ability of CZ-EO to reactivate the efficacy of fluconazole when formulated at synergic concentrations. Finally, biochemical tests were made to study the mechanism of action of CZ-EO. These studies show that in the presence of both fluconazole and CZ-EO, the activity of fungal ATPases decreases and, at the same time, the amount of intracellular drug increases. This study highlights how small doses of CZ-EO are able to inhibit the secretion of fluconazole and promote its accumulation in the fungal cell. In this manner, the drug is able to exert its pharmacological effects bypassing the resistance of the yeast. If further studies will confirm this synergy, it will be possible to develop new therapeutic formulations active in the fight against C. auris resistances.
耳念珠菌是一种耐多药真菌,已知是一个全球公共卫生问题。基于皮肤的传播,加上对药物的显著耐药性,导致其迅速传播到各大洲。本研究的目的是鉴定一种对耳念珠菌有抗菌活性的精油(EO)。总共对15种精油针对10株耳念珠菌临床菌株进行了测试。精油(CZ-EO)最为有效(MIC90和MFC90均等于0.06%体积/体积)。对从CZ-EO中获得的三个馏分以及主要化学成分肉桂醛(CIN)进行了测试,以确定对抗耳念珠菌的主要有效成分。所有含CIN的样品均显示出抗真菌活性。为了研究与氟康唑的协同作用,在棋盘试验中对CZ-EO、其活性馏分(FR2)和CIN进行了测试。结果表明,CZ-EO和FR2与氟康唑有协同作用,但CIN没有。此外,只有在药物治疗浓度(分别为0.45±0.32μg/mL和0.64±0.67μg/mL)下,CZ-EO或FR2与氟康唑共同存在时才有协同作用,而CIN仅显示相加活性。对大蜡螟幼虫进行的研究表明,高达16%体积/体积浓度的CZ-EO没有毒性,并且当以协同浓度配制时,CZ-EO能够恢复氟康唑的疗效。最后,进行了生化试验以研究CZ-EO的作用机制。这些研究表明,在氟康唑和CZ-EO同时存在的情况下,真菌ATP酶的活性降低,同时细胞内药物量增加。本研究突出了小剂量的CZ-EO如何能够抑制氟康唑的分泌并促进其在真菌细胞中的积累。通过这种方式,该药物能够绕过酵母的耐药性发挥其药理作用。如果进一步的研究证实这种协同作用,将有可能开发出对抗耳念珠菌耐药性的新型治疗制剂。